WATER IV PCa (AS Sub-study)
← catalyst calendarNCT07650448 · readout ≤ 865 d
Sponsored by PROCEPT BioRobotics (industry) · PRCT — their whole pipeline →.
Phase
Not applicable
Status
Not yet recruiting
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
333estimated
Sites
25
Countries
Hong Kong, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Sep 2026 | estimated | When the study began enrolling |
| Primary completion | Dec 2028 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2038 | estimated | The whole study's end, after follow-up |
| First posted | 2026-06-16 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-04 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Localized Prostate Cancer
Interventions
- Device: Aquablation Therapy
- Other: Active Surveillance
Primary outcome
what the primary-completion date above is the date OFFreedom from GG ≥ 2
measured 12 Months
Permalink · PRCT's whole pipeline · Catalyst calendar · Every registered study · What changed